Circulating TP53 Mutations Are Associated with Early Tumor Progression and Poor Survival in Pancreatic Cancer Patients Treated with FOLFIRINOX
Therapeutic Advances in Medical Oncology(2021)
Key words
circulating tumor DNA,FOLFIRINOX,pancreatic cancer,predictive biomarker,TP53
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined